In July 2026, Cheiron announced an $8 million seed round led by Menlo Ventures , bringing total funding to $13 million to date, with the backing and strategic support of industry veterans including Moderna co-founder and MIT Institute Professor Robert Langer, former Pfizer Chief Medical Officer Freda Lewis-Hall, Chai Discovery co-founder and CEO Josh Meier, former Starbucks CEO Laxman Narasimhan, and former Apple AI chief John Giannandrea. The company's platform helps biopharma teams represent, reason over, and stress-test the full state of a drug development program, including the claims, evidence, assumptions, risks, decisions, and commitments that determine whether a therapy advances.